Poster Session: TRIAL DESIGN, STATISTICAL INNOVATION, AND ANALYTICAL FRAMEWORKS
Title: Plasma p-tau217 In Early Alzheimer’s Disease Trial Screening: Insights from START
Authors: Marina Ritchie1, Oliver Langford1, Yixuan Liang1, Daniel Burns2, Charlene Flournoy1, Joshua D. Grill3, Anthony Caggiano4, Michael Grundman5, Robert A. Rissman1, Paul Aisen1, Christopher H. Van Dyck6, Rema Raman1
Affiliations: 1) Alzheimer’s Therapeutic Research Institute, USC; 2) University of Kansas; 3) University of California, Irvine; 4) Cognition Therapeutics, Inc.; 5) Global R&D Partners; 6) Yale School of Medicine
